Antibacterial mechanism of Kratom (Mitragyna speciosa) methanol extract on Streptococcus pneumoniae and Eschericia coli bacteria

Salim, Hotimah Masdan and Puspitarini, Marinda Dwi and Setiwati, Yuani and Shimabukuro, Michio (2021) Antibacterial mechanism of Kratom (Mitragyna speciosa) methanol extract on Streptococcus pneumoniae and Eschericia coli bacteria. Biomolecular and Health Science Journal, 4 (2). pp. 99-103. ISSN 2620-8636

Preview	PDF Antibacterial mechanism of Kratom (Mitragyna speciosa) methanol extract on Streptococcus pneumoniae and Eschericia coli bacteria.pdf Download (783kB) | Preview
Preview	PDF peer review hotimah masdan salim.pdf Download (755kB) | Preview
Preview	PDF turnitin hotimah masdan salim.pdf Download (1MB) | Preview
	PDF peer review marinda dwi puspitarini.pdf Download (748kB)
Preview	PDF turnitin mandira dwi puspitarini.pdf Download (2MB) | Preview

Abstract

Introduction: Kratom (Mitragyna speciosa) is a tropical herbal plant native to the North Malay Peninsula, Malaysia and Thailand. In Indonesia, kratom us a typical plant of West Kalimantan, especially in Putussibau. Kratom leaf has many pharmacological effects, one of them is antioxidant. However, the antioxidant and antimicrobial activities of Mitragyna speciosa leaf extracts are lacking. This study was to examine the effect of the methanol extract of Mitragyna speciosa (Rubiaceae Family) leaves on microorganisms Escherichia coli and Strepococcus pneumoniae. Methods: Kratom leaves were extracted with methanol as solvent. In this study, S. pneumoniae and E. coli bacteria have been used. Antibacterial activity tests were carried out at concentrations of 0.78%, 1.56%, 3.125%, 6.25%, 12.5%, 25%, 50% and 100%. Insilico was used to search for secondary metabolites and metabolite interactions in Mytragina speciosa. Results: Mitragyna speciosa leaf methanol extract was effective in inhibiting the growth of E. coli and S. pneumoniae significantly (P<0.001). The growth of e.coli was not identified from a concentration of 25% to 100%. However, there was no bacterial growth in S. pneumoniae from a concentration of 6.25% to 100%. In the insilico study it was found that the secondary metabolite of Mitragyna speciosa is quercetin, which interacts with the ATP1 protein as a predictor in the mechanism of Mitragyna speciosa as an antibacterial. Conclusion: In conclusion, there is no correlation between nutritional status and remission outcome of patients with ALL in the induction phase of therapy. However, high percentage of underweight patients shows nutrition needs special attention to improve therapy outcomes.

Item Type:	Article
Uncontrolled Keywords:	Mitragyna speciosa, Streptococcus pneumoniae, Eschericia coli, insilico, ATP1
Subjects:	R Medicine > R Medicine (General)
Divisions:	Faculty of Medicine > Program Study of Medicine
Depositing User:	Mr. . Aji
Date Deposited:	13 Dec 2022 02:33
Last Modified:	03 Aug 2023 09:16
URI:	http://repository.unusa.ac.id/id/eprint/9103

Actions (login required)

View Item